Airports - test equipment volume standards 200 l, 2,000 l, 5,000 l

You can find this article in the article group: Test benches, Volume standards
Mineral oil tradeRefineriesTesting service providerWeights and Measures Offices

Item description:

Stationary test equipment for checking dispensing quantity at airports. Consists of a 200l, 2,000l and 5,000l volume standard as a working standard. Upright volume standard with feet for checking dispensing quantity at petrol pumps, in tanker trucks or refuelling systems .

Sizes: 5l, 10l, 20l, 50l, 100l, 200l, 500l, 1,000l, 2,000l, 5,000l Tolerance: ±0.1% pursuant to PTB Volume 26 or ±0.05% pursuant to OIML (from 10l)

Test liquid:
low viscosity mineral oils or water

Material:
– for mineral oils: Stainless steel 1.4301
– for AdBlue: Stainless steel 1.4571/1.4404

Design:

  • Filling from top via the neck
  • Disposal via draining
  • Scale engraved from stainless steel
  • Displacer
  • Circular level
  • according to size with 3-4 feet
  • Bottom discharge as a ball valve or shut-off valve
  • Sight glass with drip control
  • optional: Filling pipe with sight glass for checking levels with 1-3 thermometer tubes depending on the size
  • Pre-calibration
  • Displacer


Additional options for volume standards:

  1. Air vent with deflagration flame arrestor
  2. Filling pipe with shut-off valves and sight glass for checking levels (from 100 l)
  3. Overfill protection
  4. Manhole cover (from 500 l)
  5. Material version 1.4571 (suitable for AdBlue)
pruef_20

Dear Sir or Madam,
Dear Mr Weinert,
27.04.2021


On April 30, 2021, we will open another site at Allergopharma GmbH & Co. KG in Reinbek to support COVID 19 vaccine production in the presence of Federal Minister Spahn and Minister President Günther. We would have been pleased to invite you to this opening.

Unfortunately, this was not possible due to the pandemic.
We would therefore like to take this opportunity to thank you for your extraordinary commitment to supplying equipment at short notice to support vaccine production. Allergopharma, as part of Dermapharm Holding SE, is now a further partner in the Europe-wide production network for the vaccine of BioNTech and Pfizer. This network now comprises more than a dozen important pharmaceutical manufacturers and suppliers. From now on, one of four production steps will take place in Reinbek: the vaccine formulation. This is where our mRNA active ingredient is combined with the lipids. A protective shell is created around the mRNA and the vaccine can reach its target in the body to induce the necessary immune response.


Your company has made a very important contribution to the global pandemic response with great know-how and under incredible time pressure. We would like to express our sincere thanks to you and your team! Without their commitment, the successful completion of the project would not have been possible.
We look forward to working with you in partnership in the future!

Dr. Hans-Georg Feldmeier – CEO Dermapharm SE
Dr. Sierk Poetting – CFO and COO BioNTech SE